Impact Factor
3.56
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
3.26
676 total citations
h5-index
28
h5 depth signal
Cited share
79.8%
174 of 218
Total citations
676
Citation footprint
Metric signal
3.89
External metric anchor
Self-citation
3.0%
20 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
China
394
United States
362
United Kingdom
113
India
74
Italy
72
Citing Fields of Research
Genetics & Genomics
672
Noncoding RNA
412
Oncology
113
Cytogenetics
102
Cancer & Development
99
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
1,921
Articles tracked across the journal lifetime
Indexed publication set
218
174 cited publications
Last 12 months
124
10.3 publications/month
Open access share
22.6%
28 OA publications in the last year
Leading citing country
China
394 citing publications
Leading citing field
Genetics & Genomics
672 citing publications
Latest tracked publication
18 October 2026
10 recent records available
Coverage & Indexing History
v1n1, Oct. 2009-
v1n1, Oct. 2009-
Active Coverage
Research Focus & Classification
Indexed Subjects
Genetics & Genomics
Noncoding RNA
Cytogenetics
Aging & Longevity
Oncology
Broad Categories
Genetics
Genetics & Genomics
Noncoding RNA
Cancer, Autophagy & Apoptosis
Cytogenetics
Nucleic Acids Chemistry
MeSH Descriptors
Epigenesis, Genetic
Genomics
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1080/17501911.2026.2735721
Open DOI
Evaluation of mRNA expression and DNA methylation status of immune checkpoints in the peripheral blood of COVID-19 patients
02
03
DOI 10.1080/17501911.2026.2746945
Open DOI
Cross-cohort DNA methylation analysis shows CpG island promoter hypermethylation features associated with cervical lesion grade
04
DOI 10.1080/17501911.2026.2745488
Open DOI
What can epigenomics tell us about prostate cancer disparities?
05
06
DOI 10.1080/17501911.2026.2740396
Open DOI
Cell-free DNA fragmentomics: from chromatin biology to clinical stratification
07
DOI 10.1080/17501911.2026.2740944
Open DOI
The role of linker histone H1.2 in tumor progression, resistance, and clinical translation
08
DOI 10.1080/17501911.2026.2739787
Open DOI
The future of cancer therapy? Integrating oncolytic adenoviruses with epigetic modulation
1. Oncolytic viruses (OVs) have emerged as a promising therapy for cancer considering their potential to selectively infect, replicate in, and lyse tumor cells while preserving normal tissues and s...
09
DOI 10.1080/17501911.2026.2738328
Open DOI
Twin study: genotype-dependent epigenetic factors associated with HbA1c levels
10
DOI 10.1080/17501911.2026.2730905
Open DOI
Genome-wide DNA methylation landscapes in gallbladder carcinoma: revealing shared and distinct epigenetic signatures across subtypes
1. 1.1. Gallbladder cancer (GBC) is an aggressive malignancy with poor clinical outcomes, largely due to late-stage diagnosis and limited treatment options [1]. GBC accounts for 2–3 cases per 100,0...
Bibliographical & Catalog Notes
Latest issue consulted: Vol. 2, no. 1 (Feb. 2010).
Volume 1 complete with two issues.
Also issued online.